These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 31181293

  • 21. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
    Wang X, Li M, Hu Y.
    Physiol Res; 2023 Dec 31; 72(6):833-841. PubMed ID: 38215068
    [Abstract] [Full Text] [Related]

  • 22. Aqua-soluble DDQ reduces the levels of Drp1 and Aβ and inhibits abnormal interactions between Aβ and Drp1 and protects Alzheimer's disease neurons from Aβ- and Drp1-induced mitochondrial and synaptic toxicities.
    Kuruva CS, Manczak M, Yin X, Ogunmokun G, Reddy AP, Reddy PH.
    Hum Mol Genet; 2017 Sep 01; 26(17):3375-3395. PubMed ID: 28854701
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX, Chen DF.
    Brain Res; 2015 Nov 19; 1627():177-88. PubMed ID: 26423933
    [Abstract] [Full Text] [Related]

  • 24. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, Kinoshita PF, Cazareth J, Badot C, Fragaki K, Bussiere R, Martin C, Mary R, Bauer C, Pagnotta S, Paquis-Flucklinger V, Buée-Scherrer V, Buée L, Lacas-Gervais S, Checler F, Chami M.
    Acta Neuropathol; 2021 Jan 19; 141(1):39-65. PubMed ID: 33079262
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
    Liu H, Tian T, Qin S, Li W, Zhang X, Wang X, Gao Y, Huang G.
    J Nutr Biochem; 2015 Dec 19; 26(12):1502-8. PubMed ID: 26345540
    [Abstract] [Full Text] [Related]

  • 28. Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.
    Reddy PH, Manczak M, Yin X, Reddy AP.
    J Alzheimers Dis; 2018 Dec 19; 62(4):1549-1565. PubMed ID: 29400667
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
    Lu Y, Tan L, Wang X.
    Neurosci Bull; 2019 Oct 19; 35(5):877-888. PubMed ID: 30887246
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
    Robinson A, Grösgen S, Mett J, Zimmer VC, Haupenthal VJ, Hundsdörfer B, Stahlmann CP, Slobodskoy Y, Müller UC, Hartmann T, Stein R, Grimm MO.
    Aging Cell; 2014 Apr 19; 13(2):263-72. PubMed ID: 24304563
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH.
    Hum Mol Genet; 2006 May 01; 15(9):1437-49. PubMed ID: 16551656
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
    Ji Y, Wang D, Zhang B, Lu H.
    J Integr Neurosci; 2019 Sep 30; 18(3):285-291. PubMed ID: 31601077
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-125a-3p Modulate Amyloid β-Protein through the MAPK Pathway in Alzheimer's Disease.
    Zhu XC, Zhu MZ, Lu J, Yao QY, Hu JW, Long WJ, Ruan SS, Dai WZ, Li R.
    Curr Alzheimer Res; 2023 Sep 30; 20(7):471-480. PubMed ID: 37711111
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.